![]() |
|
|
KR Courtney
Palo Alto Medical Foundation, California 94301.
The influence that drug size has on the rate of recovery of sodium channels in heart tissue has been reexamined. A drug dimension that looks at the end-on view of the molecule provides a substantially better explanation for the size dependence of repriming kinetics than does molecular weight. A quantitative model for the recovery time is provided that couples proton exchange kinetics with a drug size- dependent process that is related to recovery from inactivation. Drugs having a wider span at their aromatic end produce more slowing of the rate of recovery from inactivation.
This article has been cited by other articles:
![]() |
J.-F. Desaphy, S. Pierno, A. De Luca, P. Didonna, and D. C. Camerino Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders Mol. Pharmacol., March 1, 2003; 63(3): 659 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Luca, F. Natuzzi, J.-F. Desaphy, G. Loni, G. Lentini, C. Franchini, V. Tortorella, and D. C. Camerino Molecular Determinants of Mexiletine Structure for Potent and Use-Dependent Block of Skeletal Muscle Sodium Channels Mol. Pharmacol., February 1, 2000; 57(2): 268 - 277. [Abstract] [Full Text] |
||||
![]() |
P. Daleau, E. Lessard, M.-F. Groleau, and J. Turgeon Erythromycin Blocks the Rapid Component of the Delayed Rectifier Potassium Current and Lengthens Repolarization of Guinea Pig Ventricular Myocytes Circulation, June 15, 1995; 91(12): 3010 - 3016. [Abstract] [Full Text] |
||||